Top Stories
-
Source:
MedscapeIf approved, KarXT— a novel combination of xanomeline with trospium — will be a "landmark" drug, noted Dr. Jeffrey A. Lieberman.
Topic
-
Source:
Medpage TodayDr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
Topic
-
The Horga Lab is a psychiatry research lab that uses neuroimaging and cognitive methods to study the origins of the psychotic symptoms of schizophrenia, including hallucinations and delusions.
Topic
-
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).
Topic
Latest News
-
Source:
SalonFebruary 5, 2021A new study reveals that people with schizophrenia are roughly two-and-a-half times more likely to die if diagnosed with COVID-19 than individuals who do not have that mental illness.
Topic
-
Source:
Psychiatric TimesDecember 11, 2020“Our findings open the door for the development of treatments to target specific symptoms of psychosis depending on an individual subject’s symptom profile," says Guillermo Horga, MD, PhD
Topic
-
Source:
Psychiatric TimesDecember 2, 2020Dr. Joshua Kantrowitz discusses a recent trial of CVN058, a drug that may reduce cognitive impairments in individuals with schizophrenia.
Topic
- November 9, 2020
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation
Topic
-
Source:
MedscapeJuly 1, 2020Dr. Ragy Girgis speaks about the benefits of treating those with psychosis early in their illness.
Topic
-
Source:
Columbia Journalism ReviewJune 19, 2020Dr. Stephanie Le Melle speaks with the editor and publisher of CJR about how to report on police violence against Black sufferers of serious mental illness.
Topic
-
Source:
MedscapeJune 12, 2020"Teletherapy and virtual medication management alone may not adequately address the needs of some of the populations we serve," writes Dr. Angela Coombs.
Topic
-
Source:
Psychiatric TimesMay 15, 2020“The emergence of COVID-19 has forced health systems to transition rapidly to telehealth, while psychiatric research has ground to a halt,” writes Dr. Ragy Girgis and his co-authors.
Topic
-
Source:
Psychiatric TimesFebruary 26, 2020The results "indicate that KarXT, if approved, could represent a game-changing therapeutic advance in the treatment of patients with schizophrenia,” noted Dr. Jeffrey Lieberman.
Topic
-
Source:
MedscapeFebruary 20, 2020The study "contributes to efforts that may one day redefine the diagnostic system in psychiatry, which may have practical clinical implications," commented Dr. Tiffany Herlands.
Topic
